Edwin Choy, MD, is the director, Sarcoma Oncology Program at Massachusetts General Hospital and associate professor of medicine, Harvard Medical School
Breaking New Ground in Synovial Sarcoma: Choy on the FDA Approval of Afami-cel
In this episode of Targeted Talks, Edwin Choy, MD, PhD, discussed the FDA approval of afamitresgene autoleucel for the treatment of patients with advanced synovial sarcoma.
Afami-cel’s Mechanism of Action and Role in Synovial Sarcoma
Edwin Choy, MD, PhD, discusses the mechanism of action of afamitresgene autoleucel and the recent accelerated approval from the FDA for patients with advanced synovial sarcoma.
Advice and Future Directions for the Treatment of GIST
Edwin Choy, MD, provides key recommendations for community oncologists treating patients with gastrointestinal stromal tumor.
Adjuvant Therapy for GIST
Edwin Choy, MD, discusses adjuvant treatments for patients with gastrointestinal stromal tumors.